nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—CYP2D6—Vinorelbine—ovarian cancer	0.0687	0.213	CbGbCtD
Donepezil—CYP3A4—Topotecan—ovarian cancer	0.062	0.192	CbGbCtD
Donepezil—CYP2C9—Paclitaxel—ovarian cancer	0.0528	0.164	CbGbCtD
Donepezil—CYP3A4—Vinorelbine—ovarian cancer	0.0437	0.135	CbGbCtD
Donepezil—CYP3A4—Paclitaxel—ovarian cancer	0.0307	0.0951	CbGbCtD
Donepezil—CYP2D6—Doxorubicin—ovarian cancer	0.026	0.0806	CbGbCtD
Donepezil—CYP3A4—Docetaxel—ovarian cancer	0.0222	0.0688	CbGbCtD
Donepezil—CYP3A4—Doxorubicin—ovarian cancer	0.0165	0.0513	CbGbCtD
Donepezil—HTR2A—vein—ovarian cancer	0.00283	0.197	CbGeAlD
Donepezil—SIGMAR1—myometrium—ovarian cancer	0.00104	0.0727	CbGeAlD
Donepezil—SIGMAR1—uterine cervix—ovarian cancer	0.000813	0.0565	CbGeAlD
Donepezil—SIGMAR1—decidua—ovarian cancer	0.000774	0.0539	CbGeAlD
Donepezil—SIGMAR1—endometrium—ovarian cancer	0.000735	0.0511	CbGeAlD
Donepezil—ACHE—testis—ovarian cancer	0.000733	0.051	CbGeAlD
Donepezil—SIGMAR1—uterus—ovarian cancer	0.000677	0.0471	CbGeAlD
Donepezil—SIGMAR1—bone marrow—ovarian cancer	0.000575	0.04	CbGeAlD
Donepezil—SIGMAR1—female gonad—ovarian cancer	0.000554	0.0385	CbGeAlD
Donepezil—SIGMAR1—vagina—ovarian cancer	0.000551	0.0383	CbGeAlD
Donepezil—HTR2A—embryo—ovarian cancer	0.000535	0.0372	CbGeAlD
Donepezil—ACHE—lymph node—ovarian cancer	0.000531	0.0369	CbGeAlD
Donepezil—SIGMAR1—testis—ovarian cancer	0.000491	0.0342	CbGeAlD
Donepezil—HTR2A—epithelium—ovarian cancer	0.000437	0.0304	CbGeAlD
Donepezil—CYP2C9—female reproductive system—ovarian cancer	0.000394	0.0274	CbGeAlD
Donepezil—Loss of consciousness—Docetaxel—ovarian cancer	0.000374	0.000577	CcSEcCtD
Donepezil—Pancreatitis—Doxorubicin—ovarian cancer	0.000373	0.000577	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000373	0.000576	CcSEcCtD
Donepezil—Weight decreased—Epirubicin—ovarian cancer	0.000372	0.000575	CcSEcCtD
Donepezil—Hyperglycaemia—Epirubicin—ovarian cancer	0.000371	0.000573	CcSEcCtD
Donepezil—Cough—Docetaxel—ovarian cancer	0.000371	0.000573	CcSEcCtD
Donepezil—Angina pectoris—Doxorubicin—ovarian cancer	0.000371	0.000573	CcSEcCtD
Donepezil—Insomnia—Paclitaxel—ovarian cancer	0.00037	0.000572	CcSEcCtD
Donepezil—Pneumonia—Epirubicin—ovarian cancer	0.000369	0.00057	CcSEcCtD
Donepezil—Convulsion—Docetaxel—ovarian cancer	0.000368	0.000569	CcSEcCtD
Donepezil—Paraesthesia—Paclitaxel—ovarian cancer	0.000368	0.000568	CcSEcCtD
Donepezil—Hypertension—Docetaxel—ovarian cancer	0.000367	0.000567	CcSEcCtD
Donepezil—Infestation—Epirubicin—ovarian cancer	0.000367	0.000567	CcSEcCtD
Donepezil—Infestation NOS—Epirubicin—ovarian cancer	0.000367	0.000567	CcSEcCtD
Donepezil—Bronchitis—Doxorubicin—ovarian cancer	0.000366	0.000566	CcSEcCtD
Donepezil—Dyspnoea—Paclitaxel—ovarian cancer	0.000365	0.000564	CcSEcCtD
Donepezil—Somnolence—Paclitaxel—ovarian cancer	0.000364	0.000562	CcSEcCtD
Donepezil—HTR2A—gonad—ovarian cancer	0.000363	0.0253	CbGeAlD
Donepezil—Myalgia—Docetaxel—ovarian cancer	0.000362	0.000559	CcSEcCtD
Donepezil—Chest pain—Docetaxel—ovarian cancer	0.000362	0.000559	CcSEcCtD
Donepezil—Arthralgia—Docetaxel—ovarian cancer	0.000362	0.000559	CcSEcCtD
Donepezil—Nausea—Vinorelbine—ovarian cancer	0.000362	0.000558	CcSEcCtD
Donepezil—Renal failure—Epirubicin—ovarian cancer	0.000361	0.000557	CcSEcCtD
Donepezil—Dyspepsia—Paclitaxel—ovarian cancer	0.00036	0.000556	CcSEcCtD
Donepezil—Jaundice—Epirubicin—ovarian cancer	0.000358	0.000552	CcSEcCtD
Donepezil—Conjunctivitis—Epirubicin—ovarian cancer	0.000357	0.000551	CcSEcCtD
Donepezil—Urinary tract infection—Epirubicin—ovarian cancer	0.000357	0.000551	CcSEcCtD
Donepezil—SIGMAR1—lymph node—ovarian cancer	0.000356	0.0248	CbGeAlD
Donepezil—Dysuria—Doxorubicin—ovarian cancer	0.000356	0.00055	CcSEcCtD
Donepezil—Decreased appetite—Paclitaxel—ovarian cancer	0.000356	0.00055	CcSEcCtD
Donepezil—Dry mouth—Docetaxel—ovarian cancer	0.000354	0.000547	CcSEcCtD
Donepezil—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000354	0.000546	CcSEcCtD
Donepezil—Fatigue—Paclitaxel—ovarian cancer	0.000353	0.000545	CcSEcCtD
Donepezil—Sweating—Epirubicin—ovarian cancer	0.000352	0.000543	CcSEcCtD
Donepezil—Pollakiuria—Doxorubicin—ovarian cancer	0.000352	0.000543	CcSEcCtD
Donepezil—Constipation—Paclitaxel—ovarian cancer	0.00035	0.000541	CcSEcCtD
Donepezil—Pain—Paclitaxel—ovarian cancer	0.00035	0.000541	CcSEcCtD
Donepezil—Haematuria—Epirubicin—ovarian cancer	0.00035	0.00054	CcSEcCtD
Donepezil—Confusional state—Docetaxel—ovarian cancer	0.00035	0.00054	CcSEcCtD
Donepezil—Oedema—Docetaxel—ovarian cancer	0.000347	0.000536	CcSEcCtD
Donepezil—Weight increased—Doxorubicin—ovarian cancer	0.000347	0.000535	CcSEcCtD
Donepezil—Epistaxis—Epirubicin—ovarian cancer	0.000346	0.000534	CcSEcCtD
Donepezil—Infection—Docetaxel—ovarian cancer	0.000345	0.000532	CcSEcCtD
Donepezil—Weight decreased—Doxorubicin—ovarian cancer	0.000345	0.000532	CcSEcCtD
Donepezil—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000344	0.00053	CcSEcCtD
Donepezil—Pneumonia—Doxorubicin—ovarian cancer	0.000342	0.000527	CcSEcCtD
Donepezil—Shock—Docetaxel—ovarian cancer	0.000341	0.000527	CcSEcCtD
Donepezil—Nervous system disorder—Docetaxel—ovarian cancer	0.00034	0.000525	CcSEcCtD
Donepezil—Thrombocytopenia—Docetaxel—ovarian cancer	0.00034	0.000525	CcSEcCtD
Donepezil—Infestation—Doxorubicin—ovarian cancer	0.00034	0.000524	CcSEcCtD
Donepezil—Infestation NOS—Doxorubicin—ovarian cancer	0.00034	0.000524	CcSEcCtD
Donepezil—Feeling abnormal—Paclitaxel—ovarian cancer	0.000337	0.000521	CcSEcCtD
Donepezil—Bradycardia—Epirubicin—ovarian cancer	0.000335	0.000518	CcSEcCtD
Donepezil—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000335	0.000517	CcSEcCtD
Donepezil—Renal failure—Doxorubicin—ovarian cancer	0.000334	0.000515	CcSEcCtD
Donepezil—Haemoglobin—Epirubicin—ovarian cancer	0.000331	0.000511	CcSEcCtD
Donepezil—Jaundice—Doxorubicin—ovarian cancer	0.000331	0.000511	CcSEcCtD
Donepezil—Anorexia—Docetaxel—ovarian cancer	0.000331	0.000511	CcSEcCtD
Donepezil—Rhinitis—Epirubicin—ovarian cancer	0.00033	0.00051	CcSEcCtD
Donepezil—Urinary tract infection—Doxorubicin—ovarian cancer	0.00033	0.00051	CcSEcCtD
Donepezil—Conjunctivitis—Doxorubicin—ovarian cancer	0.00033	0.00051	CcSEcCtD
Donepezil—Hepatitis—Epirubicin—ovarian cancer	0.00033	0.000509	CcSEcCtD
Donepezil—Haemorrhage—Epirubicin—ovarian cancer	0.00033	0.000509	CcSEcCtD
Donepezil—Hypoaesthesia—Epirubicin—ovarian cancer	0.000328	0.000506	CcSEcCtD
Donepezil—Pharyngitis—Epirubicin—ovarian cancer	0.000327	0.000505	CcSEcCtD
Donepezil—Sweating—Doxorubicin—ovarian cancer	0.000326	0.000503	CcSEcCtD
Donepezil—Urinary tract disorder—Epirubicin—ovarian cancer	0.000325	0.000502	CcSEcCtD
Donepezil—Urticaria—Paclitaxel—ovarian cancer	0.000325	0.000502	CcSEcCtD
Donepezil—Oedema peripheral—Epirubicin—ovarian cancer	0.000325	0.000501	CcSEcCtD
Donepezil—HTR2A—female reproductive system—ovarian cancer	0.000324	0.0226	CbGeAlD
Donepezil—Hypotension—Docetaxel—ovarian cancer	0.000324	0.000501	CcSEcCtD
Donepezil—Haematuria—Doxorubicin—ovarian cancer	0.000324	0.0005	CcSEcCtD
Donepezil—Abdominal pain—Paclitaxel—ovarian cancer	0.000324	0.0005	CcSEcCtD
Donepezil—Body temperature increased—Paclitaxel—ovarian cancer	0.000324	0.0005	CcSEcCtD
Donepezil—Urethral disorder—Epirubicin—ovarian cancer	0.000323	0.000499	CcSEcCtD
Donepezil—Epistaxis—Doxorubicin—ovarian cancer	0.00032	0.000495	CcSEcCtD
Donepezil—Visual impairment—Epirubicin—ovarian cancer	0.000318	0.00049	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000316	0.000488	CcSEcCtD
Donepezil—Insomnia—Docetaxel—ovarian cancer	0.000314	0.000485	CcSEcCtD
Donepezil—Paraesthesia—Docetaxel—ovarian cancer	0.000312	0.000481	CcSEcCtD
Donepezil—Bradycardia—Doxorubicin—ovarian cancer	0.00031	0.000479	CcSEcCtD
Donepezil—Dyspnoea—Docetaxel—ovarian cancer	0.000309	0.000478	CcSEcCtD
Donepezil—Somnolence—Docetaxel—ovarian cancer	0.000309	0.000476	CcSEcCtD
Donepezil—Tinnitus—Epirubicin—ovarian cancer	0.000307	0.000474	CcSEcCtD
Donepezil—Haemoglobin—Doxorubicin—ovarian cancer	0.000306	0.000473	CcSEcCtD
Donepezil—Rhinitis—Doxorubicin—ovarian cancer	0.000306	0.000472	CcSEcCtD
Donepezil—Dyspepsia—Docetaxel—ovarian cancer	0.000306	0.000472	CcSEcCtD
Donepezil—Hepatitis—Doxorubicin—ovarian cancer	0.000305	0.000471	CcSEcCtD
Donepezil—Haemorrhage—Doxorubicin—ovarian cancer	0.000305	0.000471	CcSEcCtD
Donepezil—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000303	0.000468	CcSEcCtD
Donepezil—Pharyngitis—Doxorubicin—ovarian cancer	0.000303	0.000467	CcSEcCtD
Donepezil—Decreased appetite—Docetaxel—ovarian cancer	0.000302	0.000466	CcSEcCtD
Donepezil—Hypersensitivity—Paclitaxel—ovarian cancer	0.000302	0.000466	CcSEcCtD
Donepezil—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000301	0.000465	CcSEcCtD
Donepezil—CYP3A4—female reproductive system—ovarian cancer	0.0003	0.0209	CbGeAlD
Donepezil—Oedema peripheral—Doxorubicin—ovarian cancer	0.0003	0.000464	CcSEcCtD
Donepezil—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.0003	0.000463	CcSEcCtD
Donepezil—Fatigue—Docetaxel—ovarian cancer	0.000299	0.000462	CcSEcCtD
Donepezil—Urethral disorder—Doxorubicin—ovarian cancer	0.000299	0.000461	CcSEcCtD
Donepezil—Pain—Docetaxel—ovarian cancer	0.000297	0.000458	CcSEcCtD
Donepezil—Constipation—Docetaxel—ovarian cancer	0.000297	0.000458	CcSEcCtD
Donepezil—Chills—Epirubicin—ovarian cancer	0.000296	0.000456	CcSEcCtD
Donepezil—CYP2D6—female reproductive system—ovarian cancer	0.000296	0.0206	CbGeAlD
Donepezil—Arrhythmia—Epirubicin—ovarian cancer	0.000294	0.000454	CcSEcCtD
Donepezil—Visual impairment—Doxorubicin—ovarian cancer	0.000294	0.000454	CcSEcCtD
Donepezil—Asthenia—Paclitaxel—ovarian cancer	0.000294	0.000454	CcSEcCtD
Donepezil—HTR2A—vagina—ovarian cancer	0.000293	0.0204	CbGeAlD
Donepezil—Alopecia—Epirubicin—ovarian cancer	0.000291	0.00045	CcSEcCtD
Donepezil—Pruritus—Paclitaxel—ovarian cancer	0.00029	0.000447	CcSEcCtD
Donepezil—Mental disorder—Epirubicin—ovarian cancer	0.000289	0.000446	CcSEcCtD
Donepezil—Malnutrition—Epirubicin—ovarian cancer	0.000287	0.000443	CcSEcCtD
Donepezil—Erythema—Epirubicin—ovarian cancer	0.000287	0.000443	CcSEcCtD
Donepezil—Feeling abnormal—Docetaxel—ovarian cancer	0.000286	0.000442	CcSEcCtD
Donepezil—Tinnitus—Doxorubicin—ovarian cancer	0.000284	0.000439	CcSEcCtD
Donepezil—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000284	0.000438	CcSEcCtD
Donepezil—Flatulence—Epirubicin—ovarian cancer	0.000283	0.000436	CcSEcCtD
Donepezil—Tension—Epirubicin—ovarian cancer	0.000281	0.000435	CcSEcCtD
Donepezil—Dysgeusia—Epirubicin—ovarian cancer	0.000281	0.000434	CcSEcCtD
Donepezil—Diarrhoea—Paclitaxel—ovarian cancer	0.00028	0.000433	CcSEcCtD
Donepezil—Nervousness—Epirubicin—ovarian cancer	0.000279	0.00043	CcSEcCtD
Donepezil—Back pain—Epirubicin—ovarian cancer	0.000277	0.000428	CcSEcCtD
Donepezil—Muscle spasms—Epirubicin—ovarian cancer	0.000276	0.000426	CcSEcCtD
Donepezil—Abdominal pain—Docetaxel—ovarian cancer	0.000274	0.000424	CcSEcCtD
Donepezil—Body temperature increased—Docetaxel—ovarian cancer	0.000274	0.000424	CcSEcCtD
Donepezil—Chills—Doxorubicin—ovarian cancer	0.000274	0.000422	CcSEcCtD
Donepezil—Arrhythmia—Doxorubicin—ovarian cancer	0.000272	0.00042	CcSEcCtD
Donepezil—Dizziness—Paclitaxel—ovarian cancer	0.000271	0.000418	CcSEcCtD
Donepezil—Vision blurred—Epirubicin—ovarian cancer	0.00027	0.000417	CcSEcCtD
Donepezil—Alopecia—Doxorubicin—ovarian cancer	0.000269	0.000416	CcSEcCtD
Donepezil—CYP2D6—female gonad—ovarian cancer	0.000269	0.0187	CbGeAlD
Donepezil—Mental disorder—Doxorubicin—ovarian cancer	0.000267	0.000412	CcSEcCtD
Donepezil—Ill-defined disorder—Epirubicin—ovarian cancer	0.000266	0.000411	CcSEcCtD
Donepezil—Malnutrition—Doxorubicin—ovarian cancer	0.000265	0.00041	CcSEcCtD
Donepezil—Erythema—Doxorubicin—ovarian cancer	0.000265	0.00041	CcSEcCtD
Donepezil—Anaemia—Epirubicin—ovarian cancer	0.000265	0.000409	CcSEcCtD
Donepezil—Agitation—Epirubicin—ovarian cancer	0.000264	0.000407	CcSEcCtD
Donepezil—HTR2A—testis—ovarian cancer	0.000262	0.0182	CbGeAlD
Donepezil—Flatulence—Doxorubicin—ovarian cancer	0.000262	0.000404	CcSEcCtD
Donepezil—Tension—Doxorubicin—ovarian cancer	0.00026	0.000402	CcSEcCtD
Donepezil—Vomiting—Paclitaxel—ovarian cancer	0.00026	0.000402	CcSEcCtD
Donepezil—Dysgeusia—Doxorubicin—ovarian cancer	0.00026	0.000401	CcSEcCtD
Donepezil—Malaise—Epirubicin—ovarian cancer	0.000259	0.000399	CcSEcCtD
Donepezil—Rash—Paclitaxel—ovarian cancer	0.000258	0.000399	CcSEcCtD
Donepezil—Dermatitis—Paclitaxel—ovarian cancer	0.000258	0.000398	CcSEcCtD
Donepezil—Nervousness—Doxorubicin—ovarian cancer	0.000258	0.000398	CcSEcCtD
Donepezil—Vertigo—Epirubicin—ovarian cancer	0.000258	0.000398	CcSEcCtD
Donepezil—Syncope—Epirubicin—ovarian cancer	0.000257	0.000397	CcSEcCtD
Donepezil—Back pain—Doxorubicin—ovarian cancer	0.000257	0.000396	CcSEcCtD
Donepezil—Headache—Paclitaxel—ovarian cancer	0.000257	0.000396	CcSEcCtD
Donepezil—Hypersensitivity—Docetaxel—ovarian cancer	0.000256	0.000395	CcSEcCtD
Donepezil—Muscle spasms—Doxorubicin—ovarian cancer	0.000255	0.000394	CcSEcCtD
Donepezil—Loss of consciousness—Epirubicin—ovarian cancer	0.000252	0.000389	CcSEcCtD
Donepezil—Cough—Epirubicin—ovarian cancer	0.00025	0.000386	CcSEcCtD
Donepezil—Vision blurred—Doxorubicin—ovarian cancer	0.00025	0.000386	CcSEcCtD
Donepezil—Asthenia—Docetaxel—ovarian cancer	0.000249	0.000384	CcSEcCtD
Donepezil—Convulsion—Epirubicin—ovarian cancer	0.000249	0.000384	CcSEcCtD
Donepezil—Hypertension—Epirubicin—ovarian cancer	0.000248	0.000382	CcSEcCtD
Donepezil—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000246	0.00038	CcSEcCtD
Donepezil—Pruritus—Docetaxel—ovarian cancer	0.000246	0.000379	CcSEcCtD
Donepezil—Anaemia—Doxorubicin—ovarian cancer	0.000245	0.000379	CcSEcCtD
Donepezil—Arthralgia—Epirubicin—ovarian cancer	0.000244	0.000377	CcSEcCtD
Donepezil—Myalgia—Epirubicin—ovarian cancer	0.000244	0.000377	CcSEcCtD
Donepezil—Chest pain—Epirubicin—ovarian cancer	0.000244	0.000377	CcSEcCtD
Donepezil—Agitation—Doxorubicin—ovarian cancer	0.000244	0.000377	CcSEcCtD
Donepezil—Anxiety—Epirubicin—ovarian cancer	0.000243	0.000376	CcSEcCtD
Donepezil—Nausea—Paclitaxel—ovarian cancer	0.000243	0.000375	CcSEcCtD
Donepezil—Discomfort—Epirubicin—ovarian cancer	0.000241	0.000372	CcSEcCtD
Donepezil—Malaise—Doxorubicin—ovarian cancer	0.000239	0.000369	CcSEcCtD
Donepezil—Dry mouth—Epirubicin—ovarian cancer	0.000239	0.000369	CcSEcCtD
Donepezil—CYP2D6—testis—ovarian cancer	0.000239	0.0166	CbGeAlD
Donepezil—Vertigo—Doxorubicin—ovarian cancer	0.000238	0.000368	CcSEcCtD
Donepezil—Syncope—Doxorubicin—ovarian cancer	0.000238	0.000367	CcSEcCtD
Donepezil—Diarrhoea—Docetaxel—ovarian cancer	0.000237	0.000367	CcSEcCtD
Donepezil—Confusional state—Epirubicin—ovarian cancer	0.000236	0.000364	CcSEcCtD
Donepezil—Oedema—Epirubicin—ovarian cancer	0.000234	0.000361	CcSEcCtD
Donepezil—Loss of consciousness—Doxorubicin—ovarian cancer	0.000233	0.00036	CcSEcCtD
Donepezil—Infection—Epirubicin—ovarian cancer	0.000233	0.000359	CcSEcCtD
Donepezil—Cough—Doxorubicin—ovarian cancer	0.000232	0.000358	CcSEcCtD
Donepezil—Shock—Epirubicin—ovarian cancer	0.00023	0.000356	CcSEcCtD
Donepezil—Convulsion—Doxorubicin—ovarian cancer	0.00023	0.000355	CcSEcCtD
Donepezil—Nervous system disorder—Epirubicin—ovarian cancer	0.00023	0.000354	CcSEcCtD
Donepezil—Dizziness—Docetaxel—ovarian cancer	0.00023	0.000354	CcSEcCtD
Donepezil—Thrombocytopenia—Epirubicin—ovarian cancer	0.000229	0.000354	CcSEcCtD
Donepezil—Hypertension—Doxorubicin—ovarian cancer	0.000229	0.000354	CcSEcCtD
Donepezil—Hyperhidrosis—Epirubicin—ovarian cancer	0.000226	0.000349	CcSEcCtD
Donepezil—Arthralgia—Doxorubicin—ovarian cancer	0.000226	0.000349	CcSEcCtD
Donepezil—Chest pain—Doxorubicin—ovarian cancer	0.000226	0.000349	CcSEcCtD
Donepezil—Myalgia—Doxorubicin—ovarian cancer	0.000226	0.000349	CcSEcCtD
Donepezil—Anxiety—Doxorubicin—ovarian cancer	0.000225	0.000348	CcSEcCtD
Donepezil—Discomfort—Doxorubicin—ovarian cancer	0.000223	0.000345	CcSEcCtD
Donepezil—Anorexia—Epirubicin—ovarian cancer	0.000223	0.000344	CcSEcCtD
Donepezil—Dry mouth—Doxorubicin—ovarian cancer	0.000221	0.000341	CcSEcCtD
Donepezil—Vomiting—Docetaxel—ovarian cancer	0.000221	0.000341	CcSEcCtD
Donepezil—Rash—Docetaxel—ovarian cancer	0.000219	0.000338	CcSEcCtD
Donepezil—Hypotension—Epirubicin—ovarian cancer	0.000219	0.000338	CcSEcCtD
Donepezil—Dermatitis—Docetaxel—ovarian cancer	0.000219	0.000338	CcSEcCtD
Donepezil—Confusional state—Doxorubicin—ovarian cancer	0.000218	0.000337	CcSEcCtD
Donepezil—Headache—Docetaxel—ovarian cancer	0.000217	0.000336	CcSEcCtD
Donepezil—Oedema—Doxorubicin—ovarian cancer	0.000217	0.000334	CcSEcCtD
Donepezil—Infection—Doxorubicin—ovarian cancer	0.000215	0.000332	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000213	0.000329	CcSEcCtD
Donepezil—Shock—Doxorubicin—ovarian cancer	0.000213	0.000329	CcSEcCtD
Donepezil—Nervous system disorder—Doxorubicin—ovarian cancer	0.000212	0.000328	CcSEcCtD
Donepezil—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000212	0.000327	CcSEcCtD
Donepezil—Insomnia—Epirubicin—ovarian cancer	0.000212	0.000327	CcSEcCtD
Donepezil—Paraesthesia—Epirubicin—ovarian cancer	0.00021	0.000325	CcSEcCtD
Donepezil—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000209	0.000323	CcSEcCtD
Donepezil—Dyspnoea—Epirubicin—ovarian cancer	0.000209	0.000322	CcSEcCtD
Donepezil—Somnolence—Epirubicin—ovarian cancer	0.000208	0.000321	CcSEcCtD
Donepezil—Anorexia—Doxorubicin—ovarian cancer	0.000206	0.000319	CcSEcCtD
Donepezil—Nausea—Docetaxel—ovarian cancer	0.000206	0.000318	CcSEcCtD
Donepezil—Dyspepsia—Epirubicin—ovarian cancer	0.000206	0.000318	CcSEcCtD
Donepezil—Decreased appetite—Epirubicin—ovarian cancer	0.000204	0.000314	CcSEcCtD
Donepezil—Hypotension—Doxorubicin—ovarian cancer	0.000202	0.000312	CcSEcCtD
Donepezil—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000202	0.000312	CcSEcCtD
Donepezil—Fatigue—Epirubicin—ovarian cancer	0.000202	0.000312	CcSEcCtD
Donepezil—Constipation—Epirubicin—ovarian cancer	0.0002	0.000309	CcSEcCtD
Donepezil—Pain—Epirubicin—ovarian cancer	0.0002	0.000309	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000197	0.000305	CcSEcCtD
Donepezil—Insomnia—Doxorubicin—ovarian cancer	0.000196	0.000302	CcSEcCtD
Donepezil—Paraesthesia—Doxorubicin—ovarian cancer	0.000195	0.0003	CcSEcCtD
Donepezil—Dyspnoea—Doxorubicin—ovarian cancer	0.000193	0.000298	CcSEcCtD
Donepezil—Feeling abnormal—Epirubicin—ovarian cancer	0.000193	0.000298	CcSEcCtD
Donepezil—Somnolence—Doxorubicin—ovarian cancer	0.000193	0.000297	CcSEcCtD
Donepezil—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000191	0.000296	CcSEcCtD
Donepezil—Dyspepsia—Doxorubicin—ovarian cancer	0.000191	0.000294	CcSEcCtD
Donepezil—Decreased appetite—Doxorubicin—ovarian cancer	0.000188	0.000291	CcSEcCtD
Donepezil—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000187	0.000289	CcSEcCtD
Donepezil—Fatigue—Doxorubicin—ovarian cancer	0.000187	0.000288	CcSEcCtD
Donepezil—Urticaria—Epirubicin—ovarian cancer	0.000186	0.000287	CcSEcCtD
Donepezil—Constipation—Doxorubicin—ovarian cancer	0.000185	0.000286	CcSEcCtD
Donepezil—Pain—Doxorubicin—ovarian cancer	0.000185	0.000286	CcSEcCtD
Donepezil—Abdominal pain—Epirubicin—ovarian cancer	0.000185	0.000286	CcSEcCtD
Donepezil—Body temperature increased—Epirubicin—ovarian cancer	0.000185	0.000286	CcSEcCtD
Donepezil—Feeling abnormal—Doxorubicin—ovarian cancer	0.000179	0.000276	CcSEcCtD
Donepezil—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000177	0.000273	CcSEcCtD
Donepezil—Hypersensitivity—Epirubicin—ovarian cancer	0.000172	0.000266	CcSEcCtD
Donepezil—Urticaria—Doxorubicin—ovarian cancer	0.000172	0.000266	CcSEcCtD
Donepezil—Abdominal pain—Doxorubicin—ovarian cancer	0.000171	0.000264	CcSEcCtD
Donepezil—Body temperature increased—Doxorubicin—ovarian cancer	0.000171	0.000264	CcSEcCtD
Donepezil—Asthenia—Epirubicin—ovarian cancer	0.000168	0.000259	CcSEcCtD
Donepezil—Pruritus—Epirubicin—ovarian cancer	0.000166	0.000256	CcSEcCtD
Donepezil—Diarrhoea—Epirubicin—ovarian cancer	0.00016	0.000247	CcSEcCtD
Donepezil—Hypersensitivity—Doxorubicin—ovarian cancer	0.00016	0.000246	CcSEcCtD
Donepezil—Asthenia—Doxorubicin—ovarian cancer	0.000155	0.00024	CcSEcCtD
Donepezil—Dizziness—Epirubicin—ovarian cancer	0.000155	0.000239	CcSEcCtD
Donepezil—Pruritus—Doxorubicin—ovarian cancer	0.000153	0.000237	CcSEcCtD
Donepezil—Vomiting—Epirubicin—ovarian cancer	0.000149	0.00023	CcSEcCtD
Donepezil—Diarrhoea—Doxorubicin—ovarian cancer	0.000148	0.000229	CcSEcCtD
Donepezil—Rash—Epirubicin—ovarian cancer	0.000148	0.000228	CcSEcCtD
Donepezil—Dermatitis—Epirubicin—ovarian cancer	0.000147	0.000228	CcSEcCtD
Donepezil—Headache—Epirubicin—ovarian cancer	0.000147	0.000226	CcSEcCtD
Donepezil—Dizziness—Doxorubicin—ovarian cancer	0.000143	0.000221	CcSEcCtD
Donepezil—Nausea—Epirubicin—ovarian cancer	0.000139	0.000215	CcSEcCtD
Donepezil—Vomiting—Doxorubicin—ovarian cancer	0.000138	0.000213	CcSEcCtD
Donepezil—Rash—Doxorubicin—ovarian cancer	0.000137	0.000211	CcSEcCtD
Donepezil—Dermatitis—Doxorubicin—ovarian cancer	0.000136	0.000211	CcSEcCtD
Donepezil—Headache—Doxorubicin—ovarian cancer	0.000136	0.000209	CcSEcCtD
Donepezil—Nausea—Doxorubicin—ovarian cancer	0.000129	0.000199	CcSEcCtD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	2.94e-05	0.00195	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	2.86e-05	0.0019	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—ovarian cancer	2.83e-05	0.00188	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PGR—ovarian cancer	2.78e-05	0.00185	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PPP1CC—ovarian cancer	2.72e-05	0.0018	CbGpPWpGaD
Donepezil—ACHE—Metabolism—BRIP1—ovarian cancer	2.72e-05	0.0018	CbGpPWpGaD
Donepezil—ACHE—Phospholipid metabolism—PIK3CA—ovarian cancer	2.62e-05	0.00174	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—PIK3CG—ovarian cancer	2.62e-05	0.00174	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—DLC1—ovarian cancer	2.6e-05	0.00172	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	2.59e-05	0.00172	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PARP1—ovarian cancer	2.59e-05	0.00172	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	2.59e-05	0.00171	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.48e-05	0.00165	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—CASP3—ovarian cancer	2.48e-05	0.00164	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—IL6ST—ovarian cancer	2.48e-05	0.00164	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	2.45e-05	0.00162	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	2.39e-05	0.00158	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	2.38e-05	0.00158	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—PIK3CG—ovarian cancer	2.38e-05	0.00158	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	2.33e-05	0.00154	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	2.33e-05	0.00154	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—PIK3CD—ovarian cancer	2.3e-05	0.00153	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.24e-05	0.00149	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	2.2e-05	0.00146	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	2.12e-05	0.00141	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—BCL9—ovarian cancer	2.12e-05	0.0014	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	2.1e-05	0.00139	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PPP2R1A—ovarian cancer	2.1e-05	0.00139	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	2.1e-05	0.00139	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—PIK3CD—ovarian cancer	2.09e-05	0.00139	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	2.02e-05	0.00134	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—PIK3CB—ovarian cancer	2.01e-05	0.00133	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.98e-05	0.00131	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NME2—ovarian cancer	1.98e-05	0.00131	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NME2—ovarian cancer	1.96e-05	0.0013	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.95e-05	0.0013	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—CXCL8—ovarian cancer	1.93e-05	0.00128	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—IL2—ovarian cancer	1.84e-05	0.00122	CbGpPWpGaD
Donepezil—ACHE—Metabolism—YAP1—ovarian cancer	1.82e-05	0.00121	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—PIK3CB—ovarian cancer	1.82e-05	0.00121	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.81e-05	0.0012	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.8e-05	0.00119	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—CXCL8—ovarian cancer	1.75e-05	0.00116	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—MAPK1—ovarian cancer	1.72e-05	0.00114	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—IL2—ovarian cancer	1.67e-05	0.00111	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—DOK1—ovarian cancer	1.67e-05	0.00111	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TERT—ovarian cancer	1.67e-05	0.00111	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.67e-05	0.0011	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.65e-05	0.00109	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—ovarian cancer	1.61e-05	0.00107	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.59e-05	0.00105	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PPP1CC—ovarian cancer	1.57e-05	0.00104	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CAV1—ovarian cancer	1.54e-05	0.00102	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—ovarian cancer	1.54e-05	0.00102	CbGpPWpGaD
Donepezil—ACHE—Metabolism—FASN—ovarian cancer	1.49e-05	0.000986	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ESR1—ovarian cancer	1.49e-05	0.000985	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	1.48e-05	0.000983	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—ovarian cancer	1.47e-05	0.000971	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—ovarian cancer	1.46e-05	0.000971	CbGpPWpGaD
Donepezil—ACHE—Metabolism—SLC5A5—ovarian cancer	1.46e-05	0.00097	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL6ST—ovarian cancer	1.46e-05	0.000969	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—IL6—ovarian cancer	1.46e-05	0.000964	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—PIK3CA—ovarian cancer	1.42e-05	0.000942	CbGpPWpGaD
Donepezil—ACHE—Metabolism—SLC2A1—ovarian cancer	1.41e-05	0.000936	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—APC—ovarian cancer	1.41e-05	0.000931	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CG—ovarian cancer	1.41e-05	0.000931	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—NRAS—ovarian cancer	1.41e-05	0.000931	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—ovarian cancer	1.38e-05	0.000917	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.38e-05	0.000917	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—MMP2—ovarian cancer	1.38e-05	0.000916	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—HRAS—ovarian cancer	1.38e-05	0.000915	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.36e-05	0.0009	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CYP1B1—ovarian cancer	1.35e-05	0.000898	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—MAPK3—ovarian cancer	1.35e-05	0.000892	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NME2—ovarian cancer	1.3e-05	0.000858	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—MAPK1—ovarian cancer	1.28e-05	0.000849	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—EGFR—ovarian cancer	1.28e-05	0.000849	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYTB—ovarian cancer	1.28e-05	0.000846	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—ovarian cancer	1.27e-05	0.000843	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYTB—ovarian cancer	1.27e-05	0.000839	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.24e-05	0.00082	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CD—ovarian cancer	1.24e-05	0.000819	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—PIK3CA—ovarian cancer	1.22e-05	0.000811	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—KRAS—ovarian cancer	1.21e-05	0.000802	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PPP2R1A—ovarian cancer	1.2e-05	0.000796	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.2e-05	0.000792	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HDAC6—ovarian cancer	1.19e-05	0.00079	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PPP2R1A—ovarian cancer	1.18e-05	0.00078	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ovarian cancer	1.18e-05	0.000779	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—CXCL8—ovarian cancer	1.15e-05	0.000761	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—CXCL8—ovarian cancer	1.13e-05	0.000749	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ovarian cancer	1.13e-05	0.000746	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—BRIP1—ovarian cancer	1.12e-05	0.000739	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PPP1CC—ovarian cancer	1.12e-05	0.000739	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ABCB1—ovarian cancer	1.12e-05	0.000739	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—PIK3CA—ovarian cancer	1.11e-05	0.000736	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.11e-05	0.000733	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.11e-05	0.000733	CbGpPWpGaD
Donepezil—ACHE—Metabolism—TYMS—ovarian cancer	1.1e-05	0.000726	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ERBB2—ovarian cancer	1.09e-05	0.000723	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MTOR—ovarian cancer	1.08e-05	0.000714	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CB—ovarian cancer	1.08e-05	0.000714	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—CTNNB1—ovarian cancer	1.06e-05	0.000702	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—YAP1—ovarian cancer	1.06e-05	0.0007	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CXCL8—ovarian cancer	1.03e-05	0.000686	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—XIAP—ovarian cancer	1.03e-05	0.000685	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—HRAS—ovarian cancer	1.03e-05	0.000681	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CDKN1B—ovarian cancer	1.01e-05	0.00067	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SMARCA4—ovarian cancer	1.01e-05	0.000668	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—AKT1—ovarian cancer	1e-05	0.000662	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CASP3—ovarian cancer	9.91e-06	0.000656	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL2—ovarian cancer	9.89e-06	0.000655	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—IL6—ovarian cancer	9.84e-06	0.000652	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EREG—ovarian cancer	9.84e-06	0.000652	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CCND1—ovarian cancer	9.64e-06	0.000639	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CTNNB1—ovarian cancer	9.55e-06	0.000633	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MMP9—ovarian cancer	9.36e-06	0.00062	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PTEN—ovarian cancer	9.31e-06	0.000617	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PGR—ovarian cancer	9.22e-06	0.000611	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—AKT1—ovarian cancer	9.08e-06	0.000602	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CAV1—ovarian cancer	8.83e-06	0.000585	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CG—ovarian cancer	8.67e-06	0.000575	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PARP1—ovarian cancer	8.57e-06	0.000568	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.44e-06	0.000559	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—VEGFA—ovarian cancer	8.41e-06	0.000557	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYTB—ovarian cancer	8.35e-06	0.000553	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—STAT3—ovarian cancer	8.32e-06	0.000552	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NRAS—ovarian cancer	8.3e-06	0.00055	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL6ST—ovarian cancer	8.2e-06	0.000543	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.06e-06	0.000534	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CG—ovarian cancer	8.04e-06	0.000533	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MAPK3—ovarian cancer	7.95e-06	0.000527	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CG—ovarian cancer	7.88e-06	0.000522	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MYC—ovarian cancer	7.73e-06	0.000512	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CD—ovarian cancer	7.63e-06	0.000505	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MAPK1—ovarian cancer	7.57e-06	0.000501	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—EGFR—ovarian cancer	7.56e-06	0.000501	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—YAP1—ovarian cancer	7.49e-06	0.000496	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—YAP1—ovarian cancer	7.42e-06	0.000492	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.34e-06	0.000487	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.3e-06	0.000483	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.3e-06	0.000483	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—KRAS—ovarian cancer	7.15e-06	0.000474	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CD—ovarian cancer	7.07e-06	0.000469	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PPP2R1A—ovarian cancer	6.95e-06	0.000461	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CD—ovarian cancer	6.92e-06	0.000459	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CB—ovarian cancer	6.65e-06	0.00044	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CA—ovarian cancer	6.57e-06	0.000435	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.46e-06	0.000428	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CXCL8—ovarian cancer	6.39e-06	0.000423	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TP53—ovarian cancer	6.35e-06	0.000421	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CB—ovarian cancer	6.16e-06	0.000408	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—IL2—ovarian cancer	6.1e-06	0.000404	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—FASN—ovarian cancer	6.1e-06	0.000404	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HRAS—ovarian cancer	6.07e-06	0.000402	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—FASN—ovarian cancer	6.05e-06	0.000401	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CB—ovarian cancer	6.04e-06	0.0004	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SLC5A5—ovarian cancer	6e-06	0.000398	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SLC5A5—ovarian cancer	5.95e-06	0.000394	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL6—ovarian cancer	5.81e-06	0.000385	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CXCL8—ovarian cancer	5.8e-06	0.000384	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SLC2A1—ovarian cancer	5.8e-06	0.000384	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SLC2A1—ovarian cancer	5.75e-06	0.000381	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.63e-06	0.000373	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP1B1—ovarian cancer	5.56e-06	0.000368	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL2—ovarian cancer	5.54e-06	0.000367	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TERT—ovarian cancer	5.52e-06	0.000366	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP1B1—ovarian cancer	5.51e-06	0.000365	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—AKT1—ovarian cancer	5.36e-06	0.000355	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTEN—ovarian cancer	5.33e-06	0.000353	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CAV1—ovarian cancer	5.11e-06	0.000338	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	4.93e-06	0.000327	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ESR1—ovarian cancer	4.92e-06	0.000326	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—YAP1—ovarian cancer	4.89e-06	0.000324	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	4.89e-06	0.000324	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.86e-06	0.000322	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL6ST—ovarian cancer	4.84e-06	0.000321	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CG—ovarian cancer	4.65e-06	0.000308	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APC—ovarian cancer	4.65e-06	0.000308	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—NRAS—ovarian cancer	4.65e-06	0.000308	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ABCB1—ovarian cancer	4.58e-06	0.000303	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ABCB1—ovarian cancer	4.54e-06	0.000301	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—TYMS—ovarian cancer	4.49e-06	0.000298	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—MAPK3—ovarian cancer	4.46e-06	0.000295	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—TYMS—ovarian cancer	4.46e-06	0.000295	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—MAPK1—ovarian cancer	4.24e-06	0.000281	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—EGFR—ovarian cancer	4.24e-06	0.000281	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CD—ovarian cancer	4.09e-06	0.000271	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CA—ovarian cancer	4.05e-06	0.000268	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—KRAS—ovarian cancer	4e-06	0.000265	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—FASN—ovarian cancer	3.99e-06	0.000264	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.92e-06	0.00026	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.79e-06	0.000251	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CA—ovarian cancer	3.76e-06	0.000249	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CA—ovarian cancer	3.68e-06	0.000244	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.63e-06	0.000241	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CAV1—ovarian cancer	3.62e-06	0.00024	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ERBB2—ovarian cancer	3.61e-06	0.000239	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CAV1—ovarian cancer	3.59e-06	0.000238	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CB—ovarian cancer	3.57e-06	0.000236	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MTOR—ovarian cancer	3.57e-06	0.000236	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.43e-06	0.000227	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCL8—ovarian cancer	3.43e-06	0.000227	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—HRAS—ovarian cancer	3.4e-06	0.000226	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CDKN1B—ovarian cancer	3.35e-06	0.000222	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AKT1—ovarian cancer	3.31e-06	0.000219	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CG—ovarian cancer	3.3e-06	0.000219	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CASP3—ovarian cancer	3.28e-06	0.000217	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL2—ovarian cancer	3.27e-06	0.000217	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CG—ovarian cancer	3.27e-06	0.000217	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL6—ovarian cancer	3.26e-06	0.000216	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.22e-06	0.000214	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCND1—ovarian cancer	3.19e-06	0.000212	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CTNNB1—ovarian cancer	3.16e-06	0.000209	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MMP9—ovarian cancer	3.1e-06	0.000205	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PTEN—ovarian cancer	3.08e-06	0.000204	CbGpPWpGaD
Donepezil—ACHE—Metabolism—AKT1—ovarian cancer	3.07e-06	0.000203	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AKT1—ovarian cancer	3.01e-06	0.000199	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.99e-06	0.000198	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TYMS—ovarian cancer	2.94e-06	0.000195	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CD—ovarian cancer	2.9e-06	0.000192	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.88e-06	0.000191	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—VEGFA—ovarian cancer	2.78e-06	0.000184	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—STAT3—ovarian cancer	2.76e-06	0.000183	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NRAS—ovarian cancer	2.75e-06	0.000182	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAPK3—ovarian cancer	2.63e-06	0.000174	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MYC—ovarian cancer	2.56e-06	0.00017	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.53e-06	0.000168	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.51e-06	0.000166	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAPK1—ovarian cancer	2.5e-06	0.000166	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EGFR—ovarian cancer	2.5e-06	0.000166	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CAV1—ovarian cancer	2.37e-06	0.000157	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KRAS—ovarian cancer	2.37e-06	0.000157	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTEN—ovarian cancer	2.18e-06	0.000145	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CA—ovarian cancer	2.17e-06	0.000144	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTEN—ovarian cancer	2.17e-06	0.000143	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.16e-06	0.000143	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TP53—ovarian cancer	2.1e-06	0.000139	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HRAS—ovarian cancer	2.01e-06	0.000133	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL6—ovarian cancer	1.92e-06	0.000128	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.9e-06	0.000126	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AKT1—ovarian cancer	1.78e-06	0.000118	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.65e-06	0.00011	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.54e-06	0.000102	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.53e-06	0.000101	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTEN—ovarian cancer	1.43e-06	9.46e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—AKT1—ovarian cancer	1.26e-06	8.34e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—AKT1—ovarian cancer	1.25e-06	8.27e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.01e-06	6.68e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AKT1—ovarian cancer	8.23e-07	5.45e-05	CbGpPWpGaD
